Molecular Docking Studies of Spirostans as MAPK14 (P38α) Inhibitors and Their Potential Use against Cancer
Spirostans (SPs) are chemical products widely distributed in the plant kingdom; currently, they are studied by their medical applications. Cancer has a high incidence in humans; it reaches second place worldwide deaths. In molecular biology, it has been accepted that Mitogen-Activated Protein p38alp...
Saved in:
Main Authors: | Guiee Niza Lopez-Castillo (Author), Victorino Alatriste (Author), Jesus Sandoval-Ramírez (Author), Felix Luna (Author), Alan Carrasco-Carballo (Author) |
---|---|
Format: | Book |
Published: |
Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
p38 MAPK, microglial signaling, and neuropathic pain
by: Suter Marc R, et al.
Published: (2007) -
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
by: Utid Suriya, et al.
Published: (2022) -
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
by: Mark C. Bagley, et al.
Published: (2010) -
p38β - MAPK11 and its role in female cancers
by: Periklis Katopodis, et al.
Published: (2021) -
The functional role of p38 MAPK pathway in malignant brain tumors
by: Nathália Grave, et al.
Published: (2022)